Barro, Eduardo D.
HRN: 21-88-35 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2022
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
10/02/2022
10/09/2022
OPHTHALMIC
0.5%
TIDO
Bacterial Conjunctivitis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes